An Early Phase Study of RT-114 (RaniPill Containing PG-102, a GLP-1/2 Dual Agonist) in Healthy Volunteers.

NCT06891287 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

COMBINATION_PRODUCT: RT-114 is the RaniPill capsule with PG-102 for the treatment of obesity
DRUG: PG-102
OTHER: Placebo

Sponsor

RANI Therapeutics